Insider Trading June 4, 2026 04:28 PM

Verisk Analytics Director Samuel Liss Exercises Options and Sells $1.2M in Stock

Insider transaction follows a 44% annual decline in VRSK shares, as the company advances AI integration and undergoes board restructuring.

By Sofia Navarro VRSK

Verisk Analytics, Inc. (NASDAQ: VRSK) reported a significant insider transaction involving director Samuel G. Liss, who liquidated a portion of his holdings following the exercise of stock options. This sale occurs amidst a period of market contraction for the company's stock, which has declined 44% over the past year. Concurrently, Verisk is navigating corporate governance updates, including a new board appointment, and is actively expanding its technological infrastructure through new AI integrations. Analyst sentiment remains cautiously optimistic, with price target adjustments reflecting confidence in the company's financial resilience despite the recent stock performance.

Verisk Analytics Director Samuel Liss Exercises Options and Sells $1.2M in Stock
VRSK

Key Points

  • Verisk Analytics director Samuel Liss sold $1.2 million in stock after exercising options, reducing his direct holdings to 69,098 shares.
  • The company is integrating its insurance analytics with Anthropic's Claude AI platform, launching tools like the Underwriting Intelligence connector to enhance data utilization for insurers.
  • Raymond James lowered its price target to $230 but maintained a Strong Buy rating, citing confidence in Verisk's free cash flow and $1.5 billion share repurchase program.

Samuel G. Liss, a director at Verisk Analytics, Inc. (NASDAQ: VRSK), executed a substantial transaction involving the company's common stock on June 2, 2026. The director sold shares totaling $1,201,666, a move that was directly preceded by the exercise of stock options. This transaction highlights the mechanics of executive compensation and liquidity events within the data analytics sector.

The sale involved the disposition of 6,765 shares of Verisk Analytics common stock. These shares were traded at a price of $177.63 per share. Prior to the sale, Mr. Liss had acquired an identical quantity of 6,765 shares through the exercise of stock options. The exercise price for these options was $80.93 per share, resulting in a total acquisition value of $547,491. The options utilized in this transaction were outstanding under the company's 2013 Equity Incentive Plan and were noted as being immediately exercisable at the time of the transaction.

Following the completion of these trades, Mr. Liss's direct holdings in Verisk Analytics common stock stand at 69,098 shares. This insider activity takes place against a backdrop of significant stock price volatility. Verisk shares have experienced a 44% decline over the past year. As of the reporting period, the stock was trading at $180. Market analysis from InvestingPro suggests that the stock may be undervalued at current levels, citing the company's strong operational metrics. Specifically, the analysis points to impressive gross profit margins of 70% as a key indicator of financial health.

Corporate governance updates are also underway at Verisk Analytics. During the company's recent annual meeting, shareholders approved all eleven nominees to the board of directors. A notable addition to the board is Pradip Patiath, a senior partner at McKinsey & Company. Mr. Patiath has joined the board effective immediately, bringing external expertise to the company's oversight structure.

Financial market participants have also adjusted their outlooks. Raymond James recently revised its price target for Verisk Analytics, lowering the estimate from $260 to $230. Despite this downward revision, the firm maintained a Strong Buy rating on the stock. This adjustment follows Verisk's execution of a $1.5 billion accelerated share repurchase program. The company has also engaged in additional share purchases, actions that are interpreted as demonstrating confidence in its free cash flow generation and long-term strategic outlook.

On the product development front, Verisk has launched new AI connectors for its Claude insurance platform. These connectors serve to integrate Verisk's insurance analytics capabilities with Anthropic's Claude AI platform. The integration introduces specific tools, including the Verisk Underwriting Intelligence connector and the XactRestore connector. These tools are designed to enable insurers and restoration contractors to access and utilize data more effectively. These developments underscore Verisk's ongoing efforts to enhance its technological capabilities and strengthen its market position within the insurance and risk management sectors.

The intersection of insider trading activity, stock performance, and corporate strategy provides a complex picture for investors. While the stock has faced headwinds, the company's financial margins and cash flow initiatives suggest underlying resilience. The expansion into AI-driven analytics represents a strategic pivot to maintain competitiveness in a rapidly evolving technological landscape.

Risks

  • Verisk shares have declined 44% over the past year, indicating significant market volatility and potential investor concern regarding short-term performance.
  • The adjustment of the price target by Raymond James from $260 to $230 suggests a cautious outlook among financial analysts despite the maintained buy rating.
  • The integration of third-party AI platforms like Anthropic's Claude introduces technological dependencies and execution risks associated with new software partnerships.

More from Insider Trading

Krispy Kreme Director Bernardo Hees Executes $2.1 Million Share Purchase Amid Financial Headwinds Jun 4, 2026 Genelux Regulatory Chief Executes Minor Stock Sale for Tax Obligations Jun 4, 2026 QuantumScape Executive Timothy Holme Offloads $1.77 Million in Shares Amid Market Volatility Jun 4, 2026 Janux Therapeutics Executive Janeen Doyle Offloads Stock for Tax Obligations Jun 4, 2026 Hilltop Holdings Director Bobbitt Disposes of $380K in Shares Amid Strong Q1 Earnings Jun 4, 2026